Virginia | 001-12658 | 54-1692118 | ||
(State or other jurisdiction of incorporation) | (Commission file number) | (IRS employer identification no.) | ||
4350 Congress Street, Suite 700, Charlotte, North Carolina | 28209 | |||
(Address of principal executive offices) | (Zip code) |
Emerging growth company | ¨ |
By: | /s/ Karen G. Narwold |
Karen G. Narwold | |
Executive Vice President and Chief Administrative Officer |
Exhibit | ||
Number | Exhibit | |
Contact: | |
Eric Norris | 980.299.5518 |
• | Fourth quarter net sales were $857.8 million, an increase of 23% over the prior year |
• | Fourth quarter loss of $218.4 million, or $1.95 per diluted share, included $366.9 million of income tax expense related to the new U.S. tax reform laws |
• | Fourth quarter adjusted EBITDA was $245.8 million, an increase of 31% over the prior year; adjusted diluted earnings per share from continuing operations of $1.34, an increase of 72% over the prior year |
• | Signed definitive agreement to sell the polyolefin catalysts and components portion of its PCS business |
• | Expect adjusted diluted earnings per share in 2018 between $5.00 and $5.40, an increase of 9% to 18% over 2017 |
Three Months Ended | Twelve Months Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
In thousands, except per share amounts | 2017 | 2016 | 2017 | 2016 | |||||||||||
Net sales | $ | 857,789 | $ | 696,655 | $ | 3,071,976 | $ | 2,677,203 | |||||||
Net (loss) income from continuing operations | $ | (207,071 | ) | $ | 50,304 | $ | 99,468 | $ | 478,638 | ||||||
Net (loss) income attributable to Albemarle Corporation | $ | (218,366 | ) | $ | 602,090 | $ | 54,850 | $ | 643,675 | ||||||
Adjusted EBITDA | $ | 245,780 | $ | 187,384 | $ | 885,480 | $ | 758,217 | |||||||
Diluted (loss) earnings per share attributable to Albemarle Corporation | $ | (1.95 | ) | $ | 5.30 | $ | 0.49 | $ | 5.68 | ||||||
Non-operating pension and OPEB items(a) | (0.08 | ) | 0.16 | (0.09 | ) | 0.16 | |||||||||
Non-recurring and other unusual items(a) | 3.36 | 0.25 | 4.20 | (0.49 | ) | ||||||||||
Discontinued operations(b) | — | (4.93 | ) | — | (1.78 | ) | |||||||||
Adjusted diluted earnings per share from continuing operations(c) | $ | 1.34 | $ | 0.78 | $ | 4.59 | $ | 3.57 |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net sales | $ | 857,789 | $ | 696,655 | $ | 3,071,976 | $ | 2,677,203 | |||||||
Cost of goods sold | 550,780 | 455,689 | 1,961,996 | 1,706,627 | |||||||||||
Gross profit | 307,009 | 240,966 | 1,109,980 | 970,576 | |||||||||||
Selling, general and administrative expenses | 108,632 | 125,476 | 437,901 | 380,464 | |||||||||||
Research and development expenses | 20,907 | 19,091 | 84,330 | 80,475 | |||||||||||
Gain on sales of businesses, net | — | — | — | (122,298 | ) | ||||||||||
Acquisition and integration related costs | — | 13,047 | — | 57,384 | |||||||||||
Operating profit | 177,470 | 83,352 | 587,749 | 574,551 | |||||||||||
Interest and financing expenses | (16,455 | ) | (18,321 | ) | (115,350 | ) | (65,181 | ) | |||||||
Other (expenses) income, net | (19,089 | ) | 5,154 | (25,601 | ) | 5,894 | |||||||||
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | 141,926 | 70,185 | 446,798 | 515,264 | |||||||||||
Income tax expense | 378,221 | 34,728 | 431,817 | 96,263 | |||||||||||
(Loss) income from continuing operations before equity in net income of unconsolidated investments | (236,295 | ) | 35,457 | 14,981 | 419,001 | ||||||||||
Equity in net income of unconsolidated investments (net of tax) | 29,224 | 14,847 | 84,487 | 59,637 | |||||||||||
Net (loss) income from continuing operations | (207,071 | ) | 50,304 | 99,468 | 478,638 | ||||||||||
Income from discontinued operations (net of tax)(b) | — | 559,974 | — | 202,131 | |||||||||||
Net (loss) income | (207,071 | ) | 610,278 | 99,468 | 680,769 | ||||||||||
Net income attributable to noncontrolling interests | (11,295 | ) | (8,188 | ) | (44,618 | ) | (37,094 | ) | |||||||
Net (loss) income attributable to Albemarle Corporation | $ | (218,366 | ) | $ | 602,090 | $ | 54,850 | $ | 643,675 | ||||||
Basic (loss) earnings per share: | |||||||||||||||
Continuing operations | $ | (1.98 | ) | $ | 0.37 | $ | 0.49 | $ | 3.93 | ||||||
Discontinued operations | — | 4.98 | — | 1.80 | |||||||||||
$ | (1.98 | ) | $ | 5.35 | $ | 0.49 | $ | 5.73 | |||||||
Diluted (loss) earnings per share: | |||||||||||||||
Continuing operations | $ | (1.95 | ) | $ | 0.37 | $ | 0.49 | $ | 3.90 | ||||||
Discontinued operations | — | 4.93 | — | 1.78 | |||||||||||
$ | (1.95 | ) | $ | 5.30 | $ | 0.49 | $ | 5.68 | |||||||
Weighted-average common shares outstanding – basic | 110,510 | 112,487 | 110,914 | 112,379 | |||||||||||
Weighted-average common shares outstanding – diluted | 112,152 | 113,563 | 112,380 | 113,239 |
December 31, | December 31, | ||||||
2017 | 2016 | ||||||
ASSETS | |||||||
Cash and cash equivalents | $ | 1,137,303 | $ | 2,269,756 | |||
Other current assets | 1,301,108 | 1,036,862 | |||||
Assets held for sale | 39,152 | — | |||||
Total current assets | 2,477,563 | 3,306,618 | |||||
Property, plant and equipment | 4,124,335 | 3,910,522 | |||||
Less accumulated depreciation and amortization | 1,631,025 | 1,550,382 | |||||
Net property, plant and equipment | 2,493,310 | 2,360,140 | |||||
Noncurrent assets held for sale | 139,813 | — | |||||
Other assets and intangibles | 2,640,086 | 2,494,449 | |||||
Total assets | $ | 7,750,772 | $ | 8,161,207 | |||
LIABILITIES AND EQUITY | |||||||
Current portion of long-term debt | $ | 422,012 | $ | 247,544 | |||
Other current liabilities | 776,975 | 892,559 | |||||
Liabilities held for sale | 1,938 | — | |||||
Total current liabilities | 1,200,925 | 1,140,103 | |||||
Long-term debt | 1,415,360 | 2,121,718 | |||||
Noncurrent liabilities held for sale | 614 | — | |||||
Other noncurrent liabilities | 945,788 | 544,043 | |||||
Deferred income taxes | 370,389 | 412,739 | |||||
Albemarle Corporation shareholders’ equity | 3,674,549 | 3,795,062 | |||||
Noncontrolling interests | 143,147 | 147,542 | |||||
Total liabilities and equity | $ | 7,750,772 | $ | 8,161,207 |
Year Ended | |||||||
December 31, | |||||||
2017 | 2016 | ||||||
Cash and cash equivalents at beginning of year | $ | 2,269,756 | $ | 213,734 | |||
Cash and cash equivalents at end of period | $ | 1,137,303 | $ | 2,269,756 | |||
Sources of cash and cash equivalents: | |||||||
Net income | $ | 99,468 | $ | 680,769 | |||
Cash proceeds from divestitures, net | 6,857 | 3,325,571 | |||||
Proceeds from borrowings of long-term debt | 27,000 | — | |||||
Other borrowings, net | 138,751 | — | |||||
Dividends received from unconsolidated investments and nonmarketable securities | 39,386 | 43,759 | |||||
Proceeds from exercise of stock options | 8,238 | 9,401 | |||||
Working capital changes(d) | — | 239,195 | |||||
Uses of cash and cash equivalents: | |||||||
Working capital changes(d) | (392,263 | ) | — | ||||
Capital expenditures | (317,703 | ) | (196,654 | ) | |||
Acquisitions, net of cash acquired | (44,367 | ) | (126,747 | ) | |||
Cash payments related to acquisitions and other | — | (81,987 | ) | ||||
Repayments of long-term debt | (778,209 | ) | (1,252,302 | ) | |||
Repurchases of common stock | (250,000 | ) | — | ||||
Repayments of other borrowings, net | — | (163,721 | ) | ||||
Pension and postretirement contributions | (13,341 | ) | (20,068 | ) | |||
Dividends paid to shareholders | (140,557 | ) | (135,353 | ) | |||
Fees related to early extinguishment of debt | (46,959 | ) | — | ||||
Dividends paid to noncontrolling interests | (36,756 | ) | (35,855 | ) | |||
Non-cash and other items: | |||||||
Depreciation and amortization | 196,928 | 226,169 | |||||
Gain on sales of businesses, net | — | (510,278 | ) | ||||
Gain on acquisition | (6,221 | ) | — | ||||
Pension and postretirement (benefit) expense | (12,436 | ) | 41,546 | ||||
Loss on early extinguishment of debt | 52,801 | 1,921 | |||||
Deferred income taxes | (41,941 | ) | 21,121 | ||||
Equity in net income of unconsolidated investments (net of tax) | (84,487 | ) | (61,534 | ) |
(a) | See Non-GAAP Reconciliations for a description of the Non-operating pension and OPEB items and Non-recurring and other unusual items. |
(c) | Totals may not add due to rounding. |
(d) | The change in working capital increased $239.2 million for the year ended December 31, 2016 primarily as a result of the increase in income taxes payable from the gain on the sale of the Chemetall Surface Treatment business. During the year ended December 31, 2017, these income taxes of $257 million were paid, primarily driving the decrease in the change in working capital of $392.3 million, along with the build up of inventory in our Lithium and Advanced Materials reportable segment. |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net sales: | |||||||||||||||
Lithium and Advanced Materials | $ | 362,362 | $ | 278,266 | $ | 1,308,153 | $ | 968,216 | |||||||
Bromine Specialties | 219,084 | 194,513 | 855,143 | 792,425 | |||||||||||
Refining Solutions | 238,400 | 193,093 | 778,304 | 732,137 | |||||||||||
All Other | 37,770 | 30,001 | 128,914 | 180,988 | |||||||||||
Corporate | 173 | 782 | 1,462 | 3,437 | |||||||||||
Total net sales | $ | 857,789 | $ | 696,655 | $ | 3,071,976 | $ | 2,677,203 | |||||||
Adjusted EBITDA: | |||||||||||||||
Lithium and Advanced Materials | $ | 135,741 | $ | 102,499 | $ | 518,530 | $ | 363,360 | |||||||
Bromine Specialties | 64,402 | 46,949 | 258,901 | 226,926 | |||||||||||
Refining Solutions | 69,228 | 57,343 | 212,005 | 238,963 | |||||||||||
All Other | 5,972 | (38 | ) | 13,878 | 14,772 | ||||||||||
Corporate(a) | (29,563 | ) | (19,369 | ) | (117,834 | ) | (85,804 | ) | |||||||
Total adjusted EBITDA | $ | 245,780 | $ | 187,384 | $ | 885,480 | $ | 758,217 |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net sales: | |||||||||||||||
Lithium | $ | 289,597 | $ | 208,173 | $ | 1,018,885 | $ | 668,852 | |||||||
PCS | 72,765 | 70,093 | 289,268 | 299,364 | |||||||||||
Total Lithium and Advanced Materials | $ | 362,362 | $ | 278,266 | $ | 1,308,153 | $ | 968,216 | |||||||
Adjusted EBITDA: | |||||||||||||||
Lithium | $ | 118,656 | $ | 89,097 | $ | 446,652 | $ | 285,714 | |||||||
PCS | 17,085 | 13,402 | 71,878 | 77,646 | |||||||||||
Total Lithium and Advanced Materials | $ | 135,741 | $ | 102,499 | $ | 518,530 | $ | 363,360 |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net (loss) income attributable to Albemarle Corporation | $ | (218,366 | ) | $ | 602,090 | $ | 54,850 | $ | 643,675 | ||||||
Add back: | |||||||||||||||
Income from discontinued operations (net of tax) | — | (559,974 | ) | — | (202,131 | ) | |||||||||
Earnings from continuing operations | (218,366 | ) | 42,116 | 54,850 | 441,544 | ||||||||||
Add back: | |||||||||||||||
Non-operating pension and OPEB items from continuing operations (net of tax) | (8,455 | ) | 17,868 | (10,548 | ) | 17,608 | |||||||||
Non-recurring and other unusual items from continuing operations (net of tax) | 376,641 | 28,844 | 471,559 | (55,374 | ) | ||||||||||
Adjusted net income from continuing operations | $ | 149,820 | $ | 88,828 | $ | 515,861 | $ | 403,778 | |||||||
Adjusted diluted earnings per share from continuing operations | $ | 1.34 | $ | 0.78 | $ | 4.59 | $ | 3.57 | |||||||
Weighted-average common shares outstanding – diluted | 112,152 | 113,563 | 112,380 | 113,239 | |||||||||||
Net (loss) income attributable to Albemarle Corporation | $ | (218,366 | ) | $ | 602,090 | $ | 54,850 | $ | 643,675 | ||||||
Add back: | |||||||||||||||
Income from discontinued operations (net of tax) | — | (559,974 | ) | — | (202,131 | ) | |||||||||
Interest and financing expenses | 16,455 | 18,321 | 115,350 | 65,181 | |||||||||||
Income tax expense | 378,221 | 34,728 | 431,817 | 96,263 | |||||||||||
Depreciation and amortization | 52,841 | 49,687 | 196,928 | 190,975 | |||||||||||
EBITDA | 229,151 | 144,852 | 798,945 | 793,963 | |||||||||||
Non-operating pension and OPEB items | (12,981 | ) | 26,368 | (16,125 | ) | 25,589 | |||||||||
Non-recurring and other unusual items (excluding items associated with interest expense) | 29,610 | 16,164 | 102,660 | (61,335 | ) | ||||||||||
Adjusted EBITDA | $ | 245,780 | $ | 187,384 | $ | 885,480 | $ | 758,217 | |||||||
Net sales | $ | 857,789 | $ | 696,655 | $ | 3,071,976 | $ | 2,677,203 | |||||||
EBITDA margin | 26.7 | % | 20.8 | % | 26.0 | % | 29.7 | % | |||||||
Adjusted EBITDA margin | 28.7 | % | 26.9 | % | 28.8 | % | 28.3 | % |
Lithium and Advanced Materials | Bromine Specialties | Refining Solutions | Reportable Segments Total | All Other | Corporate | Consolidated Total | % of Net Sales | |||||||||||||||||||||||
Three months ended December 31, 2017: | ||||||||||||||||||||||||||||||
Net income (loss) attributable to Albemarle Corporation | $ | 107,705 | $ | 54,646 | $ | 57,968 | $ | 220,319 | $ | 3,899 | $ | (442,584 | ) | $ | (218,366 | ) | (25.5 | )% | ||||||||||||
Depreciation and amortization | 28,232 | 9,756 | 11,260 | 49,248 | 2,073 | 1,520 | 52,841 | 6.2 | % | |||||||||||||||||||||
Non-recurring and other unusual items | (196 | ) | — | — | (196 | ) | — | 29,806 | 29,610 | 3.5 | % | |||||||||||||||||||
Interest and financing expenses | — | — | — | — | — | 16,455 | 16,455 | 1.9 | % | |||||||||||||||||||||
Income tax expense | — | — | — | — | — | 378,221 | 378,221 | 44.1 | % | |||||||||||||||||||||
Non-operating pension and OPEB items | — | — | — | — | — | (12,981 | ) | (12,981 | ) | (1.5 | )% | |||||||||||||||||||
Adjusted EBITDA | $ | 135,741 | $ | 64,402 | $ | 69,228 | $ | 269,371 | $ | 5,972 | $ | (29,563 | ) | $ | 245,780 | 28.7 | % | |||||||||||||
Three months ended December 31, 2016: | ||||||||||||||||||||||||||||||
Net income (loss) attributable to Albemarle Corporation | $ | 75,021 | $ | 37,143 | $ | 48,107 | $ | 160,271 | $ | (1,711 | ) | $ | 443,530 | $ | 602,090 | 86.5 | % | |||||||||||||
Depreciation and amortization | 27,478 | 9,806 | 9,236 | 46,520 | 1,673 | 1,494 | 49,687 | 7.1 | % | |||||||||||||||||||||
Non-recurring and other unusual items (excluding items associated with interest expense) | — | — | — | — | — | 16,164 | 16,164 | 2.3 | % | |||||||||||||||||||||
Interest and financing expenses | — | — | — | — | — | 18,321 | 18,321 | 2.6 | % | |||||||||||||||||||||
Income tax expense | — | — | — | — | — | 34,728 | 34,728 | 5.0 | % | |||||||||||||||||||||
Income from discontinued operations (net of tax) | — | — | — | — | — | (559,974 | ) | (559,974 | ) | (80.4 | )% | |||||||||||||||||||
Non-operating pension and OPEB items | — | — | — | — | — | 26,368 | 26,368 | 3.8 | % | |||||||||||||||||||||
Adjusted EBITDA | $ | 102,499 | $ | 46,949 | $ | 57,343 | $ | 206,791 | $ | (38 | ) | $ | (19,369 | ) | $ | 187,384 | 26.9 | % | ||||||||||||
Year ended December 31, 2017: | ||||||||||||||||||||||||||||||
Net income (loss) attributable to Albemarle Corporation | $ | 400,360 | $ | 218,839 | $ | 173,297 | $ | 792,496 | $ | 5,521 | $ | (743,167 | ) | $ | 54,850 | 1.8 | % | |||||||||||||
Depreciation and amortization | 102,389 | 40,062 | 39,958 | 182,409 | 8,357 | 6,162 | 196,928 | 6.4 | % | |||||||||||||||||||||
Non-recurring and other unusual items (excluding items associated with interest expense) | 15,781 | — | (1,250 | ) | 14,531 | — | 88,129 | 102,660 | 3.3 | % | ||||||||||||||||||||
Interest and financing expenses | — | — | — | — | — | 115,350 | 115,350 | 3.7 | % | |||||||||||||||||||||
Income tax expense | — | — | — | — | — | 431,817 | 431,817 | 14.1 | % | |||||||||||||||||||||
Non-operating pension and OPEB items | — | — | — | — | — | (16,125 | ) | (16,125 | ) | (0.5 | )% | |||||||||||||||||||
Adjusted EBITDA | $ | 518,530 | $ | 258,901 | $ | 212,005 | $ | 989,436 | $ | 13,878 | $ | (117,834 | ) | $ | 885,480 | 28.8 | % | |||||||||||||
Year ended December 31, 2016: | ||||||||||||||||||||||||||||||
Net income (loss) attributable to Albemarle Corporation | $ | 261,394 | $ | 187,364 | $ | 202,874 | $ | 651,632 | $ | 131,301 | $ | (139,258 | ) | $ | 643,675 | 24.0 | % | |||||||||||||
Depreciation and amortization | 101,966 | 39,562 | 36,089 | 177,617 | 7,302 | 6,056 | 190,975 | 7.1 | % | |||||||||||||||||||||
Non-recurring and other unusual items (excluding items associated with interest expense) | — | — | — | — | (123,831 | ) | 62,496 | (61,335 | ) | (2.3 | )% | |||||||||||||||||||
Interest and financing expenses | — | — | — | — | — | 65,181 | 65,181 | 2.4 | % | |||||||||||||||||||||
Income tax expense | — | — | — | — | — | 96,263 | 96,263 | 3.6 | % | |||||||||||||||||||||
Income from discontinued operations (net of tax) | — | — | — | — | — | (202,131 | ) | (202,131 | ) | (7.6 | )% | |||||||||||||||||||
Non-operating pension and OPEB items | — | — | — | — | — | 25,589 | 25,589 | 1.0 | % | |||||||||||||||||||||
Adjusted EBITDA | $ | 363,360 | $ | 226,926 | $ | 238,963 | $ | 829,249 | $ | 14,772 | $ | (85,804 | ) | $ | 758,217 | 28.3 | % |
Lithium | PCS | Total Lithium and Advanced Materials | |||||||||
Three months ended December 31, 2017: | |||||||||||
Net income attributable to Albemarle Corporation | $ | 93,814 | $ | 13,891 | $ | 107,705 | |||||
Depreciation and amortization | 25,038 | 3,194 | 28,232 | ||||||||
Non-recurring and other unusual items | (196 | ) | — | (196 | ) | ||||||
Adjusted EBITDA | $ | 118,656 | $ | 17,085 | $ | 135,741 | |||||
Three months ended December 31, 2016: | |||||||||||
Net income attributable to Albemarle Corporation | $ | 65,529 | $ | 9,492 | $ | 75,021 | |||||
Depreciation and amortization | 23,568 | 3,910 | 27,478 | ||||||||
Adjusted EBITDA | $ | 89,097 | $ | 13,402 | $ | 102,499 | |||||
Year ended December 31, 2017: | |||||||||||
Net income attributable to Albemarle Corporation | $ | 342,992 | $ | 57,368 | $ | 400,360 | |||||
Depreciation and amortization | 87,879 | 14,510 | 102,389 | ||||||||
Non-recurring and other unusual items | 15,781 | — | 15,781 | ||||||||
Adjusted EBITDA | $ | 446,652 | $ | 71,878 | $ | 518,530 | |||||
Year ended December 31, 2016: | |||||||||||
Net income attributable to Albemarle Corporation | $ | 198,852 | $ | 62,542 | $ | 261,394 | |||||
Depreciation and amortization | 86,862 | 15,104 | 101,966 | ||||||||
Adjusted EBITDA | $ | 285,714 | $ | 77,646 | $ | 363,360 |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Cost of goods sold: | |||||||||||||||
MTM actuarial (gain) loss | $ | (2.6 | ) | $ | 0.3 | $ | (2.6 | ) | $ | 0.3 | |||||
Interest cost and expected return on assets, net | (0.7 | ) | (0.2 | ) | (1.1 | ) | (0.6 | ) | |||||||
Total | $ | (3.3 | ) | $ | 0.1 | $ | (3.7 | ) | $ | (0.3 | ) | ||||
Selling, general and administrative expenses: | |||||||||||||||
MTM actuarial (gain) loss | $ | (8.8 | ) | $ | 26.3 | $ | (8.8 | ) | $ | 26.3 | |||||
Interest cost and expected return on assets, net | (0.9 | ) | (0.2 | ) | (3.6 | ) | (0.4 | ) | |||||||
Total | $ | (9.7 | ) | $ | 26.1 | $ | (12.4 | ) | $ | 25.9 |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Utilization of inventory markup(1) | $ | — | $ | — | $ | 0.15 | $ | — | |||||||
Restructuring and other, net(2) | (0.01 | ) | — | 0.11 | — | ||||||||||
Acquisition and integration related costs(3) | 0.06 | 0.05 | 0.24 | 0.31 | |||||||||||
Gain on sales of businesses, net(4) | — | — | — | (1.02 | ) | ||||||||||
Gain on acquisition(5) | 0.01 | — | (0.04 | ) | — | ||||||||||
Loss on extinguishment of debt(6) | (0.04 | ) | 0.01 | 0.30 | 0.01 | ||||||||||
Multiemployer plan shortfall contributions(7) | 0.02 | — | 0.06 | — | |||||||||||
Note receivable reserve(8) | 0.18 | — | 0.18 | — | |||||||||||
Other(9) | (0.04 | ) | 0.03 | — | 0.03 | ||||||||||
Discrete tax items(10) | 3.18 | 0.16 | 3.20 | 0.18 | |||||||||||
Total non-recurring and other unusual items | $ | 3.36 | $ | 0.25 | $ | 4.20 | $ | (0.49 | ) |
(1) | In connection with the acquisition of the lithium hydroxide and lithium carbonate conversion business of Jiangxi Jiangli New Materials Science and Technology Co. Ltd. (“Jiangli New Materials”), the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.1 million. The inventory markup was expensed over the estimated remaining selling period. For the year ended December 31, 2017, $23.1 million ($17.3 million after income taxes, or $0.15 per share) was included in Cost of goods sold related to the utilization of the inventory markup. |
(2) | The year ended December 31, 2017 included restructuring costs in each of our reportable segments at several locations, primarily at our Lithium site in Germany. These restructuring costs are included in the consolidated statements of income as follows (in millions): |
Year Ended | |||
December 31, 2017 | |||
Restructuring and other costs: | |||
Cost of goods sold | $ | 2.9 | |
Selling, general and administrative expenses | 8.4 | ||
Research and development expenses | 5.7 | ||
Total | $ | 17.0 | |
Total restructuring and other costs, after income taxes | $ | 12.1 | |
Total restructuring and other costs, per diluted share | $ | 0.11 |
(3) | Acquisition and integration related costs for the three months and year ended December 31, 2017 primarily resulted from the acquisition of Jiangli New Materials. For the three months and year ended December 31, 2016, acquisition and integration related costs of $9.7 million and $52.1 million, respectively, related to integration costs resulting from the acquisition of Rockwood, and $3.3 million and $5.3 million, respectively, were in connection with other significant projects. Acquisition and integration related costs are included in the consolidated statements of income as follows (in millions): |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Acquisition and integration related costs: | |||||||||||||||
Cost of goods sold | $ | 1.8 | $ | — | $ | 14.3 | $ | — | |||||||
Selling, general and administrative expenses | 5.8 | — | 19.6 | — | |||||||||||
Acquisition and integration related costs | — | 13.0 | — | 57.4 | |||||||||||
Total | $ | 7.6 | $ | 13.0 | $ | 33.9 | $ | 57.4 | |||||||
Total acquisition and integration related costs, after income taxes | $ | 6.7 | $ | 5.9 | $ | 26.8 | $ | 35.4 | |||||||
Total acquisition and integration related costs, per diluted share | $ | 0.06 | $ | 0.05 | $ | 0.24 | $ | 0.31 |
(4) | Included in Gain on sales of businesses, net, for the year ended December 31, 2016 is $11.5 million ($11.3 million after income taxes, or $0.10 per share) related to the sale of the metal sulfides business and $112.3 million ($105.8 million after income taxes, or $0.93 per share) related to the sale of the minerals-based flame retardants and specialty chemicals businesses. In addition, Gain on sales of businesses, net, for the year ended December 31, 2016 includes a loss of $1.5 million, or $0.01 per share, on the sale of our wafer reclaim business. |
(5) | Included in Other (expenses) income, net, for the three months and year ended December 31, 2017 is a pre-tax gain of $0.2 million and $6.2 million, respectively, related to the acquisition of the remaining 50% interest in the Sales de Magnesio Ltda. joint venture in Chile. In addition, during the three months ended December 31, 2017, we adjusted the income taxes on this gain by $1.0 million. After income taxes, we recorded a loss of $0.8 million, or $0.01 per share, and a gain of $4.6 million, or $0.04 per share for the three months and year ended December 31, 2017, respectively. The gain was calculated based on the difference between the purchase price and the book value of the investment. |
(6) | Included in Interest and financing expenses for the year ended December 31, 2017 is a loss on early extinguishment of debt of $52.8 million ($33.4 million after income taxes, or $0.30 per share) related to the tender premiums, fees, unamortized discounts and unamortized deferred financing costs from the redemption of the 3.00% Senior notes, €307.0 million of the 1.875% Senior notes and $174.7 million of the 4.50% Senior notes. During the three months ended December 31, 2017, we adjusted the income taxes on this loss by $4.7 million, or $0.04 per share. Included in Interest and financing expenses for the three months and year ended December 31, 2016 is a loss on early extinguishment of debt of $1.9 million ($1.5 million after income taxes, or $0.01 per share) related to the redemption of the term loan issued in October 2015. |
(7) | Included in Selling, general and administrative expenses for the three months and year ended December, 2017 is $1.3 million and $3.3 million ($0.9 million and $2.2 million after income taxes, or $0.01 and $0.02 per share), respectively, for increased capital reserve contributions to a multiemployer plan, which is subject to a financial improvement plan. In addition, for the year ended December 31, 2017, capital reserve contributions for this multiemployer plan of $4.6 million ($0.04 per share) included in Other (expenses) income, net, have been made to indemnify previously divested businesses. During the three months ended December 31, 2017, we adjusted the income taxes on the capital reserve contributions by $1.8 million, or $0.01 per share. |
(8) | Included in Other (expenses) income, net for the three months and year ended December 31, 2017 is a $28.7 million ($20.2 million after income taxes, or $0.18 per share) reserve recorded against a note receivable in one of our European entities no longer deemed probable of collection. |
(9) | Other (expenses) income, net for the three months ended December 31, 2017 included the revision of tax indemnification expenses of $1.8 million and a $1.0 million charge related to the settlement of a legal claim, partially offset by a $10.6 million gain related to the reversal of a liability associated with the purchase accounting of a previous acquisition. After income taxes, these net gains totaled $4.2 million or $0.04 per share. |
• | Cost of goods sold - $1.3 million reversal of deferred income related to an abandoned project at an unconsolidated investment. |
• | Selling, general and administrative expenses - $1.0 million related to a reversal of an accrual recorded as part of purchase accounting from a previous acquisition. |
• | Other (expenses) income, net - $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle, loss of $4.1 million related to the final settlements of previously disposed businesses, the revision of tax indemnification expenses of $3.7 million primarily related to the filing of tax returns and a competent authority agreement for a previously disposed business and $1.0 million related to the settlement of a legal claim, partially offset by gains of $10.6 million and $1.1 million related to the reversal of liabilities recorded as part of purchase accounting from a previous acquisition and the previous disposal of a property, respectively. |
• | Selling, general and administrative expenses - $0.9 million net loss on the sales of properties. |
• | Other (expenses) income, net - $2.4 million of environmental charges related to a site formerly owned by Albemarle, a $1.1 million gain related to a previously disposed of site in China and a loss of $1.0 million on the sales of properties. |
• | Research and development expenses - $1.4 million loss resulting from the write-off of research and development fixed assets in China. |
• | Selling, general and administrative expenses - $0.9 million net loss on the sales of properties. |
• | Other (expenses) income, net - $2.4 million of environmental charges related to a site formerly owned by Albemarle, partially offset by a $1.1 million gain related to a previously disposed of site in China. |
(10) | Included in Income tax expense for the three months and year ended December 31, 2017 are discrete net income tax expenses of $356.6 million ($3.18 per share) and $359.3 million ($3.20 per share), respectively. The discrete net income tax expenses are primarily related to the enactment of the TCJA in December 2017, resulting in income tax expense of $429.2 million from a one-time transition tax on earnings on certain foreign subsidiaries that were previously tax deferred, partially offset by a $62.3 million income tax benefit as a result of reducing the U.S. federal corporate income tax rate from 35% to 21%. Included in Income tax expense (benefit) for the three months and year ended December 31, 2016 are expense items of $18.4 million ($0.16 per share) and $20.0 million ($0.18 per share), respectively, related primarily to a tax gain from restructuring the ownership of a foreign subsidiary, foreign tax rate changes, provision to return adjustments and changes in valuation allowances necessary due to the restructuring. |
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | Income tax expense | Effective income tax rate | ||||||||
Three months ended December 31, 2017: | ||||||||||
As reported | $ | 141,926 | $ | 378,221 | 266.5 | % | ||||
Non-recurring, other unusual and non-operating pension and OPEB items | 16,629 | (351,557 | ) | |||||||
As adjusted | $ | 158,555 | $ | 26,664 | 16.8 | % | ||||
Three months ended December 31, 2016: | ||||||||||
As reported | $ | 70,185 | $ | 34,728 | 49.5 | % | ||||
Non-recurring, other unusual and non-operating pension and OPEB items | 44,453 | (2,259 | ) | |||||||
As adjusted | $ | 114,638 | $ | 32,469 | 28.3 | % | ||||
Year ended December 31, 2017: | ||||||||||
As reported | $ | 446,798 | $ | 431,817 | 96.6 | % | ||||
Non-recurring, other unusual and non-operating pension and OPEB items | 139,336 | (321,675 | ) | |||||||
As adjusted | $ | 586,134 | $ | 110,142 | 18.8 | % | ||||
Year ended December 31, 2016: | ||||||||||
As reported | $ | 515,264 | $ | 96,263 | 18.7 | % | ||||
Non-recurring, other unusual and non-operating pension and OPEB items | (33,825 | ) | 3,941 | |||||||
As adjusted | $ | 481,439 | $ | 100,204 | 20.8 | % |
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
&O"<:>$YTX_3_D M.9XQ=7\OP_.3/:YKGD^&G@^6O__: @! @,!/Q#^-/_: @! P,!/Q#^-/_9 end